Publicaciones en las que colabora con Cecilio Jesús Vidal Moreno (22)

2016

  1. Cholinergic system and cell proliferation

    Chemico-Biological Interactions, Vol. 259, pp. 257-265

2015

  1. Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma

    BMC Cancer, Vol. 15, Núm. 1

  2. Unbalanced acetylcholinesterase activity in larynx squamous cell carcinoma

    International Immunopharmacology, Vol. 29, Núm. 1, pp. 81-86

2014

  1. Most acetylcholinesterase activity of non-nervous tissues and cells arises from the AChE-H transcript

    Journal of Molecular Neuroscience, Vol. 53, Núm. 3, pp. 429-435

2012

  1. Changes in the expression and structure of cholinesterases in excitable and non-excitable tissues of the merosin-deficient Lama2dy mouse, a model of congenital muscular dystrophy

    Cholinesterase: Production, Uses and Health Effects (Nova Science Publishers, Inc.), pp. 1-32

  2. Sensores moleculares: un reto para el químico, una demanda social

    Academia de Ciencias de la Región de Murcia

2007

  1. Butyrylcholinesterase activity and molecular components in thymus of healthy and merosin-deficient Lama2dy mice

    Neurochemistry International, Vol. 50, Núm. 3, pp. 531-539

2006

  1. Cholinesterase activity of human lung tumours varies according to their histological classification

    Carcinogenesis, Vol. 27, Núm. 3, pp. 429-436

  2. Thymus acetylcholinesterase activity is reduced in mice with congenital muscular dystrophy

    Journal of Molecular Neuroscience

2005

  1. (05) Acetylcholinesterase biogenesis is impaired in lung cancer tissues

    Chemico-Biological Interactions

  2. (46) Cholinesterase activity and enzyme components in healthy and cancerous human colorectal sections

    Chemico-Biological Interactions

  3. Muscular dystrophy by merosin deficiency decreases acetylcholinesterase activity in thymus of Lama2dy mice

    Journal of Neurochemistry, Vol. 95, Núm. 4, pp. 1035-1046

  4. Muscular dystrophy with laminin deficiency decreases acetylcholinesterase activity in thymus of dystrophic Lama2dy Mice

    Chemico-Biological Interactions, Vol. 157-158, pp. 431-432

2004

  1. Molecular properties of acetylcholinesterase in mouse spleen

    Neurochemistry International, Vol. 45, Núm. 1, pp. 129-139

2003

  1. Purification and properties of hydrophilic dimers of acetylcholinesterase from mouse erythrocytes

    International Journal of Biochemistry and Cell Biology, Vol. 35, Núm. 7, pp. 1109-1118

1999

  1. Amphiphilic properties of acetylcholinesterase monomers in mouse plasma

    Neuroscience Letters, Vol. 265, Núm. 3, pp. 211-214

  2. Characterization of acetylcholinesterase and butyrylcholinesterase forms in normal and dystrophic Lama2(dy) mouse heart

    Journal of Neuroscience Research, Vol. 56, Núm. 3, pp. 295-306

1993

  1. Amphiphilic and hydrophilic forms of acetyl‐ and butyrylcholinesterase in human brain

    Journal of Neuroscience Research, Vol. 35, Núm. 6, pp. 678-689

  2. Cholinesterases in cerebrospinal fluid in patients with meningitis and hydrocephaly

    Clinica Chimica Acta, Vol. 214, Núm. 2, pp. 219-225

1992

  1. Ricinus communis agglutinin I reacting and non-reacting butyrylcholinesterase in human cerebrospinal fluid

    Neuroscience Letters, Vol. 145, Núm. 1, pp. 59-62